Skip to main content
OpenTrials

Clinical trial condition

Lymphoma, B-Cell

Explore clinical trials studying Lymphoma, B-Cell. Study availability and eligibility vary by location and protocol.

504 public trials 140 recruiting studies
Refine in advanced search Browse all conditions

Lymphoma, B-Cell trial results

Completed

A Study to Learn How Safe and Tolerable Odronextamab and Cemiplimab Are in Adult Patients With B-cell Malignancies

NCT02651662

Conditions
Disease Attributes, Hemic and Lymphatic Diseases, Immune System Diseases, +12 more
Locations
  • Johns Hopkins University Baltimore, Maryland, United States
  • Dana Farber/Harvard Cancer Center - PO box 849168 Boston, Massachusetts, United States
  • Harvard Medical School - Beth Israel Deaconess Medical Center Boston, Massachusetts, United States
  • Cancer & Hematology Centers of Western Michigan Grand Rapids, Michigan, United States
View all 30 locations
View Trial Details
Completed

DPX-Survivac and Checkpoint Inhibitor in DLBCL

NCT03349450

Conditions
Adult Diffuse Large Cell Lymphoma, Adult Refractory Diffuse Large B-Cell Lymphoma, Dendritic Cell Sarcoma, Interdigitating, +18 more
Locations
  • Tom Baker Cancer Centre - Alberta Health Services Calgary, Alberta, Canada
  • Nova Scotia Health Authority: Queen Elizabeth II Health Sciences Centre Halifax, Nova Scotia, Canada
  • London Health Sciences Centre London, Ontario, Canada
  • Ottawa Hospital Research Institute Ottawa, Ontario, Canada
View Trial Details
Completed

Study Evaluating Brexucabtagene Autoleucel (KTE-X19) in Pediatric and Adolescent Participants With Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia or Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma

NCT02625480

Conditions
Disease Attributes, Hemic and Lymphatic Diseases, Immune System Diseases, +13 more
Locations
  • Children's Hospital Los Angeles Los Angeles, California, United States
  • Children's Hospital of Orange County Orange, California, United States
  • UCSF Benioff Children's Hospital San Francisco, California, United States
  • University of Miami Hospital & Clinics Miami, Florida, United States
View all 30 locations
View Trial Details
Completed

Long-term Follow-up Study for Patients Treated With CLBR001 CAR-T

NCT04488354

Conditions
Blood Protein Disorders, Burkitt Lymphoma, Cardiovascular Diseases, +47 more
Locations
  • City of Hope National Medical Center Duarte, California, United States
  • University of California at San Diego San Diego, California, United States
  • University of Chicago Chicago, Illinois, United States
  • Masonic Cancer Center, University of Minnesota Minneapolis, Minnesota, United States
View Trial Details
Completed

A Safety and Efficacy Study Evaluating CTX131 in Adult Subjects With Relapsed/Refractory Hematologic Malignancies

NCT06492304

Conditions
Acute Myeloid Leukemia, B Cell Lymphoma, Hematologic Diseases, +15 more
Locations
  • Research Site 6 Phoenix, Arizona, United States
  • Research Site 5 Stanford, California, United States
  • Research Site 3 Boston, Massachusetts, United States
  • Research Site 4 New York, United States
View Trial Details
Completed

Intergroup Randomized Trial for Children or Adolescents With B-Cell Non Hodgkin Lymphoma or B-Acute Leukemia: Rituximab Evaluation in High Risk Patients

NCT01516580

Conditions
B-cell Non Hodgkin Lymphoma, Burkitt Lymphoma, DNA Virus Infections, +16 more
Locations
  • University Hospitals Leuven Leuven, Belgium
  • Children Oncology Group Operations centres Monrovia, Canada
  • The University of Hong Kong (Clinical Trials Centre) Hong Kong, China
  • Institut de Cancérologie Gustave roussy Villejuif, France
View Trial Details

Related conditions